Class information for:
Level 1: LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//LIPOPROTEIN APHERESIS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
9600 1072 25.7 64%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2301 4109 LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LDL APHERESIS Author keyword 200 67% 17% 180
2 LOW DENSITY LIPOPROTEIN APHERESIS Author keyword 98 79% 6% 62
3 LIPOPROTEIN APHERESIS Author keyword 30 60% 3% 32
4 LIPID APHERESIS Author keyword 22 62% 2% 23
5 MEMBRANE DIFFERENTIAL FILTRATION Author keyword 21 90% 1% 9
6 DIRECT ADSORPTION OF LIPOPROTEINS Author keyword 14 100% 1% 7
7 LDL HEMOPERFUSION Author keyword 14 100% 1% 7
8 FAMILIAL HYPERCHOLESTEROLEMIA Author keyword 12 11% 10% 107
9 RHEOPHERESIS Author keyword 11 54% 1% 14
10 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA Author keyword 10 39% 2% 21

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LDL APHERESIS 200 67% 17% 180 Search LDL+APHERESIS Search LDL+APHERESIS
2 LOW DENSITY LIPOPROTEIN APHERESIS 98 79% 6% 62 Search LOW+DENSITY+LIPOPROTEIN+APHERESIS Search LOW+DENSITY+LIPOPROTEIN+APHERESIS
3 LIPOPROTEIN APHERESIS 30 60% 3% 32 Search LIPOPROTEIN+APHERESIS Search LIPOPROTEIN+APHERESIS
4 LIPID APHERESIS 22 62% 2% 23 Search LIPID+APHERESIS Search LIPID+APHERESIS
5 MEMBRANE DIFFERENTIAL FILTRATION 21 90% 1% 9 Search MEMBRANE+DIFFERENTIAL+FILTRATION Search MEMBRANE+DIFFERENTIAL+FILTRATION
6 DIRECT ADSORPTION OF LIPOPROTEINS 14 100% 1% 7 Search DIRECT+ADSORPTION+OF+LIPOPROTEINS Search DIRECT+ADSORPTION+OF+LIPOPROTEINS
7 LDL HEMOPERFUSION 14 100% 1% 7 Search LDL+HEMOPERFUSION Search LDL+HEMOPERFUSION
8 FAMILIAL HYPERCHOLESTEROLEMIA 12 11% 10% 107 Search FAMILIAL+HYPERCHOLESTEROLEMIA Search FAMILIAL+HYPERCHOLESTEROLEMIA
9 RHEOPHERESIS 11 54% 1% 14 Search RHEOPHERESIS Search RHEOPHERESIS
10 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA 10 39% 2% 21 Search HOMOZYGOUS+FAMILIAL+HYPERCHOLESTEROLEMIA Search HOMOZYGOUS+FAMILIAL+HYPERCHOLESTEROLEMIA

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LDL APHERESIS 159 58% 17% 183
2 LIPID APHERESIS 51 79% 3% 33
3 ANGIOGRAPHICALLY ASSESSED TRIAL 45 83% 2% 25
4 DENSITY LIPOPROTEIN APHERESIS 39 53% 5% 52
5 DALI APHERESIS 24 91% 1% 10
6 PRECIPITATION HELP 23 76% 1% 16
7 LDL PRECIPITATION HELP 21 90% 1% 9
8 CELLULOSE ADSORPTION SYSTEM 20 100% 1% 9
9 AMPHIPHILIC ADSORBENT 19 80% 1% 12
10 DIRECT ADSORPTION 16 58% 2% 18

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ATHEROSCLEROSIS SUPPLEMENTS 7 15% 4% 41
2 THERAPEUTIC APHERESIS 6 18% 3% 28

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Recommendations for the use of LDL apheresis 2008 122 46 89%
LDL apheresis 2003 99 84 82%
A systematic review of LDL apheresis in the treatment of cardiovascular disease 2006 37 41 78%
Efficacy criteria and cholesterol targets for LDL apheresis 2010 42 23 43%
Current management of severe homozygous hypercholesterolaemias 2004 52 79 52%
Lipoprotein apheresis: an update 2013 8 76 68%
Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature 2005 19 8 100%
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe 2010 37 36 33%
LDL apheresis: An effective and safe treatment for refractory hypercholesterolemia 2002 13 18 94%
LDL-Apheresis: Technical and Clinical Aspects 2012 9 113 46%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PLASM HE IS UNIT 4 44% 0.7% 7
2 EXTRACORPOREAL THER EUT TECH UNIT 4 46% 0.6% 6
3 AUTON NEUROENDOCRINOL 2 36% 0.5% 5
4 DOUBLE CHECK SWISS 2 67% 0.2% 2
5 MED METAB CARE GERONTOL 3 2 67% 0.2% 2
6 NEUROL INTERNAL MED 3 2 50% 0.3% 3
7 SOMAT 2 33% 0.4% 4
8 CLIN HEMOBIOTHER Y 1 100% 0.2% 2
9 EXTRACORPOREAL THER EUT TECH UNIT IMMUNOHEMATOL 1 100% 0.2% 2
10 LIPOPROT HE IS 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000154556 BILIRUBIN REMOVAL//BILIRUBIN ADSORPTION//SPECIFIC SORBENTS
2 0.0000142652 FAMILIAL HYPERCHOLESTEROLEMIA//FAMILIAL HYPERCHOLESTEROLAEMIA//LDL RECEPTOR GENE
3 0.0000118209 PARTIAL ILEAL BYPASS//POSCH//ATHEROGENIC RATIO
4 0.0000115840 THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE
5 0.0000090009 INTRAVENOUS INFUSION SETS//LIPOSORBER//ACHIRUS LINEATUS
6 0.0000083003 SEVERE HYPERTRIGLYCERIDEMIA//HYPERLIPIDEMIC PANCREATITIS//LIPEMIA RETINALIS
7 0.0000080749 ANIM PHYSIOL SECT//PROSORBA//PROTEIN A IMMOBILIZATION
8 0.0000067023 LIPOPROT UNIT//LIPOPROTEIN KINETICS//OURCE IL KINET ANAL
9 0.0000060416 LIPOPROTEINA//APOLIPOPROTEINA//LIPOPROTEIN A
10 0.0000054593 PCSK9//PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9//MIPOMERSEN